Mumbai-based start-up NeuroLeap uses technology to understand the brain and enhance its ability to perform at an optimal level.
Championing the human brain’s many wonders is Mumbai-based start-up NeuroLeap, founded by Kumaar Bagrodia in 2017. It uses technology to understand the brain and enhance its ability to perform at an optimal level. At the start-up’s centres in Mumbai and Delhi, the NeuroLeap Brain Function Assessment is priced at Rs 25,000. An individual wears the brain-computer interface (BCI) hardware with sensor points that read the brainwave activity for around 30 minutes. The data collected is compared against a global database of reference values by neuroscientists. Later, the data collected is compared against a global database of reference values by neuroscientists. After studying and analysing the data, a customised protocol is created for each client who is later followed by sessions of neurofeedback, which cost Rs 10,000 each. After clocking a total number of 200 patients in the past two years, the startup is now gearing up for growth and has raised angel funding from Rajashree Birla, Chairperson, Aditya Birla Centre for Community Initiatives and Rural Development, and Sminu Jindal, MD, Jindal Saw and Founder Chairperson, Svayam. The startup has also collaborated with certain stakeholders in the US who are backed by NASA, Defense Advanced Research Projects Agency (DARPA), National Institutes of Health (NIH), and the US Army. If that’s not all, some parts of NeuroLeap’s technologies are registered with the US Food and Drug Administration.
Mumbai, Maharashtra , India
Founder & Chief Executive Officer